A322510 Stock Overview
JLK, Inc. provides diagnosis support to the patients with it AI-driven solutions in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
JLK,Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩11,990.00 |
| 52 Week High | ₩39,050.00 |
| 52 Week Low | ₩5,590.00 |
| Beta | 1.28 |
| 1 Month Change | -3.93% |
| 3 Month Change | -25.39% |
| 1 Year Change | 112.97% |
| 3 Year Change | 52.35% |
| 5 Year Change | n/a |
| Change since IPO | 33.22% |
Recent News & Updates
Here's Why JLKInc (KOSDAQ:322510) Can Afford Some Debt
Mar 01
Here's What JLK, Inc.'s (KOSDAQ:322510) Shareholder Ownership Structure Looks Like
Dec 16
Shareholder Returns
| A322510 | KR Healthcare Services | KR Market | |
|---|---|---|---|
| 7D | 26.7% | 5.2% | 2.7% |
| 1Y | 113.0% | 26.6% | 5.8% |
Return vs Industry: A322510 exceeded the KR Healthcare Services industry which returned 26.6% over the past year.
Return vs Market: A322510 exceeded the KR Market which returned 5.8% over the past year.
Price Volatility
| A322510 volatility | |
|---|---|
| A322510 Average Weekly Movement | 11.3% |
| Healthcare Services Industry Average Movement | 7.6% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in KR Market | 11.7% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A322510's share price has been volatile over the past 3 months.
Volatility Over Time: A322510's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 56 | Dongmin Kim | www.jlkgroup.com |
JLK, Inc. provides diagnosis support to the patients with it AI-driven solutions in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides the on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases.
JLK,Inc. Fundamentals Summary
| A322510 fundamental statistics | |
|---|---|
| Market cap | ₩190.21b |
| Earnings (TTM) | -₩7.32b |
| Revenue (TTM) | ₩2.49b |
76.4x
P/S Ratio-26.0x
P/E RatioIs A322510 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A322510 income statement (TTM) | |
|---|---|
| Revenue | ₩2.49b |
| Cost of Revenue | ₩84.77m |
| Gross Profit | ₩2.40b |
| Other Expenses | ₩9.73b |
| Earnings | -₩7.32b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -461.64 |
| Gross Margin | 96.59% |
| Net Profit Margin | -294.23% |
| Debt/Equity Ratio | 153.5% |
How did A322510 perform over the long term?
See historical performance and comparison